219 related articles for article (PubMed ID: 31646123)
1. Factors affecting the haemodynamic behaviour of patients undergoing pheochromocytoma and paraganglioma removal: A review.
Ramachandran R; Rewari V
Cardiovasc Endocrinol; 2017 Jun; 6(2):73-80. PubMed ID: 31646123
[TBL] [Abstract][Full Text] [Related]
2. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma.
Pang Y; Li M; Jiang J; Chen X; Fu Y; Wang C; He Y; Zhao Y; Wang Y; Guan X; Zhang L; Xu X; Gan Y; Liu Y; Xie Y; Tang T; Wang J; Xie B; Liang Z; Chen D; Liu H; Chen C; Eisenhofer G; Liu L; Yi X; Chen BT
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2843-2853. PubMed ID: 36068986
[TBL] [Abstract][Full Text] [Related]
3. Perioperative risk factors, morbidity, and outcome of 145 patients during phaeochromocytoma resection.
Kazic MR; Zivaljevic VR; Milan ZB; Paunovic IR
Acta Chir Belg; 2011; 111(4):223-7. PubMed ID: 21954738
[TBL] [Abstract][Full Text] [Related]
4. International multicentre review of perioperative management and outcome for catecholamine-producing tumours.
Groeben H; Walz MK; Nottebaum BJ; Alesina PF; Greenwald A; Schumann R; Hollmann MW; Schwarte L; Behrends M; Rössel T; Groeben C; Schäfer M; Lowery A; Hirata N; Yamakage M; Miller JA; Cherry TJ; Nelson A; Solorzano CC; Gigliotti B; Wang TS; Wietasch JKG; Friederich P; Sheppard B; Graham PH; Weingarten TN; Sprung J
Br J Surg; 2020 Jan; 107(2):e170-e178. PubMed ID: 31903598
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Surgery for Pheochromocytoma and Paraganglioma Removal: A Retrospective Analysis of Anaesthetic Management.
Ramachandran R; Rewari V; Sharma A; Kumar R; Trikha A
Curr Hypertens Rev; 2016; 12(3):222-227. PubMed ID: 27160411
[TBL] [Abstract][Full Text] [Related]
6. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
Schreiner F; Beuschlein F
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
[TBL] [Abstract][Full Text] [Related]
7. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA
Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893
[TBL] [Abstract][Full Text] [Related]
8. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
Lam AK
Endocr Pathol; 2017 Sep; 28(3):213-227. PubMed ID: 28477311
[TBL] [Abstract][Full Text] [Related]
9. [Pheochromocytoma and paraganglioma during childhood and adolescence].
Lollert A; Miederer M; Russo A; Staatz G
Radiologie (Heidelb); 2022 Dec; 62(12):1043-1049. PubMed ID: 35948798
[TBL] [Abstract][Full Text] [Related]
10. [Catecholamine-secreting paraganglioma in a patient with Eisenmenger syndrome and a single ventricle. Nitric oxide administration and minimally invasive haemodynamic monitoring].
Uña Orejón R; Altit Millán E; Aguar Fernández M; Ureta Tolsada MP
Rev Esp Anestesiol Reanim; 2016 Mar; 63(3):172-6. PubMed ID: 26235172
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma/Paraganglioma: Review of perioperative management of blood pressure and update on genetic mutations associated with pheochromocytoma.
Fishbein L; Orlowski R; Cohen D
J Clin Hypertens (Greenwich); 2013 Jun; 15(6):428-34. PubMed ID: 23730992
[TBL] [Abstract][Full Text] [Related]
12. Perioperative haemodynamic changes in patients undergoing laparoscopic adrenalectomy for phaeochromocytomas and other adrenal tumours.
Parnaby CN; Serpell MG; Connell JM; O'Dwyer PJ
Surgeon; 2010 Feb; 8(1):9-14. PubMed ID: 20222397
[TBL] [Abstract][Full Text] [Related]
13. Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours.
Groeben H; Nottebaum BJ; Feldheiser A; Buch S; Alesina PF; Walz MK
BJA Open; 2023 Dec; 8():100240. PubMed ID: 38148968
[TBL] [Abstract][Full Text] [Related]
14. Treatment for beta-blocker poisoning: a systematic review.
Rotella JA; Greene SL; Koutsogiannis Z; Graudins A; Hung Leang Y; Kuan K; Baxter H; Bourke E; Wong A
Clin Toxicol (Phila); 2020 Oct; 58(10):943-983. PubMed ID: 32310006
[No Abstract] [Full Text] [Related]
15. [Pheochromocytoma as a challenge for the anesthesiologist].
Jovanović K; Romić P; Kovacević S; Popadić A
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():25-30. PubMed ID: 12584994
[TBL] [Abstract][Full Text] [Related]
16. The clinical genetics of phaeochromocytoma and paraganglioma.
Kavinga Gunawardane PT; Grossman A
Arch Endocrinol Metab; 2017 Oct; 61(5):490-500. PubMed ID: 29166454
[TBL] [Abstract][Full Text] [Related]
17. A family with pheochromocytoma-paraganglioma inherited tumour syndrome. Serial 18F-DOPA PET/CT investigations.
Knie B; Plotkin M; Zschieschang P; Prasad V; Moskopp D
Nuklearmedizin; 2016; 55(1):34-40. PubMed ID: 26740102
[TBL] [Abstract][Full Text] [Related]
18. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma?
Challis BG; Casey RT; Simpson HL; Gurnell M
Clin Endocrinol (Oxf); 2017 Feb; 86(2):163-167. PubMed ID: 27696513
[TBL] [Abstract][Full Text] [Related]
19. Detection of severe hypertension in a patient with neurofibromatosis type 1 during anesthesia induction: a case report.
Wang J; Wei G; Wang Z; Huang H
J Med Case Rep; 2019 Nov; 13(1):349. PubMed ID: 31783902
[TBL] [Abstract][Full Text] [Related]
20. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
